Translational Core

$866,074U19FY2016AINIH

Columbia University Health Sciences, New York NY

Investigators

Linked publications & trials

Paper 38508400 Paper 38095845 Paper 37179299 Paper 34372702 Paper 33488611 Paper 33414220 Paper 33331815 Paper 33318483 Paper 33139552 Paper 32999019 Paper 32367363 Paper 32348764 Paper 32289501 Paper 31971979 Paper 31899786 Paper 31812761 Paper 31801868 Paper 31628848 Paper 31557664 Paper 31530669 Paper 31526452 Paper 31409689 Paper 31216462 Paper 30972308 Paper 30969980 Paper 30914508 Paper 30832568 Paper 30809003 Paper 30791623 Paper 30642979 Paper 30355694 Paper 30352937 Paper 30301856 Paper 30260623 Paper 30135221 Paper 30013082 Paper 30010906 Paper 29968805 Paper 29803799 Paper 29789360 Paper 29666290 Paper 29666289 Paper 29540599 Paper 29511073 Paper 29453420 Paper 29435493 Paper 29324290 Paper 29281104 Paper 29279138 Paper 29138302 Paper 28973354 Paper 28938115 Paper 28747502 Paper 28726621 Paper 28724557 Paper 28659489 Paper 28659436 Paper 28606155 Paper 28516911 Paper 28490591 Paper 28453838 Paper 28441964 Paper 28381638 Paper 28377531 Paper 28282915 Paper 28270583 Paper 28251184 Paper 28214731 Paper 28212305 Paper 28099857 Paper 28031369 Paper 27892925 Paper 27812211 Paper 27270004 Paper 27214236 Paper 27048802 Paper 26999579 Paper 26976607 Paper 26867183 Paper 26733065 Paper 26656717 Paper 26552008 Paper 26491151 Paper 26463165 Paper 26396248 Paper 26396247 Paper 26391192 Paper 26307166 Paper 26246577 Paper 26180833 Paper 26159719 Paper 25926653 Paper 25918239 Paper 25803642 Paper 25781992 Paper 25653445 Paper 25589656 Paper 25529538 Paper 25520505 Paper 25359852

Abstract

The Translational Core is designed to support CRDD projects by collecting and supplying well characterized specimens from humans, domestic animals and wildlife with infectious diseases, and providing access to CLIA laboratories at the New York State Department of Health Wadsworth Center (NYSDOHWC) and New York City Department of Health and Mental Hygiene (NYCDOHMH) that are staffed with public health personnel who have specific expertise in optimizing and validating diagnostic assays for clinical use. All CRDD projects?whether focused on direct detection of microbial genomic targets or of host transcripts or antibodies that provide indirect evidence of infection and of insights into host response?require specimens for discovery and diagnostic assay development and validation. Through membership in regional, national and global laboratory networks, Translational Core investigators Christina Egan (NYSDOHWC), William Karesh (EcoHealth Alliance), Lipkin (Cll) and Jay Varma (NYCDOHMH) enjoy unique access to a wide range of samples and isolates to support discovery and diagnostic aims. Application of new clinical assays requires validation using specific criteria and diverse specimen matrices. In New York State, assays must be validated by the NYSDOHWC. The validation application and approval process is comprehensive and comparable to and supportive of moving the assay through the FDA approval process. By engaging NYSDOHWC and NYCDOHMH from the outset, the Translational Core is poised to expedite translation of basic research in diagnostics into products that will be used in public health and clinical laboratories and enhance the prospects for commercialization.

View original record on NIH RePORTER →